{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:04:27Z","timestamp":1760918667038,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06514"],"award-info":[{"award-number":["22K06514"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007807","name":"Japan Science Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016981","name":"Pharmaceutical Society of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016981","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bmc.2024.117606","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T20:50:30Z","timestamp":1705697430000},"page":"117606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pentafluorosulfanyl-substituted biaryl derivatives as MATE-type transporter inhibitors targeting drug-resistant bacteria"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5074-8928","authenticated-orcid":false,"given":"Susumu","family":"Shinya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-0558","authenticated-orcid":false,"given":"Kentaro","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-3399","authenticated-orcid":false,"given":"Yukiko","family":"Karuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7461-2763","authenticated-orcid":false,"given":"Atsushi","family":"Tarui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6572-602X","authenticated-orcid":false,"given":"Kazuyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1210-1768","authenticated-orcid":false,"given":"Masaaki","family":"Omote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117606_b0005","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1128\/AAC.49.5.1857-1864.2005","article-title":"Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein","volume":"49","author":"Kaatz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2024.117606_b0010","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/AAC.49.5.1865-1871.2005","article-title":"A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline","volume":"49","author":"McAleese","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2024.117606_b0015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1348-0421.2005.tb03690.x","article-title":"Gene cloning and characterization of four MATE family multidrug efflux pumps from Vibrio cholerae non-O1","volume":"49","author":"Begum","year":"2005","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.bmc.2024.117606_b0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1248\/bpb.b21-00916","article-title":"Clinical aspects of drug-drug interaction and drug nephrotoxicity at renal organic cation transporters 2 (OCT2) and multidrug and toxin exclusion 1, and 2-K (MATE1\/MATE2-K)","volume":"45","author":"Saad","year":"2022","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bmc.2024.117606_b0025","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/cts.13045","article-title":"Effects of 5-HT3 receptor antagonists on cisplatin-induced kidney injury","volume":"14","author":"Goda","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.bmc.2024.117606_b0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","article-title":"Efflux pump inhibitors for bacterial pathogens: from bench to bedside","volume":"149","author":"Sharma","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.bmc.2024.117606_b0035","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.xphs.2017.04.009","article-title":"Evaluation of renal transporter inhibition using creatinine as a substrate in vitro to assess the clinical risk of elevated serum creatinine","volume":"106","author":"Mathialagan","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bmc.2024.117606_b0040","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1248\/cpb.c21-00429","article-title":"Importance of the azole moiety of cimetidine derivatives for the inhibition of human multidrug and toxin extrusion transporter 1 (hMATE1)","volume":"69","author":"Shinya","year":"2021","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bmc.2024.117606_b0045","article-title":"Fluorophenylalkyl-substituted cyanoguanidine derivatives as bacteria-selective MATE transporter inhibitors for the treatment of antibiotic-resistant infections","volume":"15","author":"Shinya","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117606_b0050","doi-asserted-by":"crossref","first-page":"e202200291","DOI":"10.1002\/cbdv.202200291","article-title":"An overview on synthetic and medicinal perspectives of [1,2,4]triazolo[1,5-a]pyrimidine scaffold","volume":"19","author":"Merugu","year":"2022","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.bmc.2024.117606_b0055","article-title":"Membrane acting Povarov-Doebner derived compounds potently disperse preformed multidrug resistant Gram-positive bacterial biofilms","volume":"5","author":"Dayal","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117606_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115726","article-title":"Fluorinated 2-Arylcyclopropan-1-amines - a new class of sigma receptor ligands","volume":"28","author":"Schinor","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117606_b0065","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1016\/j.bmc.2017.07.039","article-title":"Fluoro and pentafluorothio analogs of the antitumoral curcuminoid EF24 with superior antiangiogenic and vascular-disruptive effects","volume":"25","author":"Schmitt","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117606_b0070","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/j.bmc.2007.08.012","article-title":"The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine","volume":"15","author":"Welch","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117606_b0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jfluchem.2012.06.030","article-title":"Synthetic chemistry and biological activity of pentafluorosulphanyl (SF5) organic molecules","volume":"143","author":"Altomonte","year":"2012","journal-title":"J Fluor Chem"},{"key":"10.1016\/j.bmc.2024.117606_b0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/JB.184.2.572-576.2002","article-title":"VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from Vibrio parahaemolyticus","volume":"184","author":"Chen","year":"2002","journal-title":"J Bacteriol"},{"key":"10.1016\/j.bmc.2024.117606_b0085","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1348-0421.2003.tb03467.x","article-title":"Molecular cloning and characterization of the HmrM multidrug efflux pump from Haemophilus influenzae Rd","volume":"47","author":"Xu","year":"2003","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.bmc.2024.117606_b0090","unstructured":"CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard. 10th ed. CLSI document M07-A102015."}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:25:51Z","timestamp":1760837151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":18,"alternative-id":["S0968089624000208"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117606","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentafluorosulfanyl-substituted biaryl derivatives as MATE-type transporter inhibitors targeting drug-resistant bacteria","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117606"}}